Following his inauguration as President of Nigeria in May 2023, Bola Tinubu announced in his inaugural address that his ...

IDEAYA Biosciences is a promising biotech company targeting genetic vulnerabilities in cancer cells with synthetic lethality.

News for GlaxoSmithKline Consumer Healthcare Ltd. HUL Faces Rs 963 Cr Income Tax Demand: Appeal Planned Hindustan Unilever (HUL) received a Rs 963 crore Income Tax demand for non-deduction of TDS on ...

Bonus Sep 11, 2018 Sep 13, 2018 Jul 24, 2018 Bonus Ratio: 1 share(s) for every 1 shares held Bonus Jan 02, 1995 Jan 24, 1995 Sep 28, 1995 Bonus Ratio: 1 share(s) for every 1 shares held Rights May 21, ...

Mirvetuximab soravtansine was the first ADC to show efficacy as a therapy for platinum-resistant ovarian cancer. Despite high ...

First Opinion is STAT’s platform for interesting, illuminating, and provocative articles about the life sciences writ large, ...

GSK PLC GSK shares slipped 2.45% to £15.36 Friday, on what proved to be an all-around grim trading session for the stock ...

The inoculation campaign is expected to lower the mortality rate in children, as malaria makes up 19 percent of child deaths ...

NKT2152, a novel HIF2a inhibitor, demonstrates significant efficacy in patients with advanced clear cell renal cell carcinoma ...

Topline results were announced from a phase 3 study assessing the immune response following coadministration of Arexvy and Shingrix.

FDA approves Lilly's eczema drug, Ebglyss, and the expanded use of Novartis' Kisqali, Merck's Keytruda and AstraZeneca's Fasenra.

Niger has become the latest West African country to roll out malaria vaccines to try to stifle the potentially deadly disease, an official source told AFP on Friday.